2022
DOI: 10.1016/j.plefa.2022.102476
|View full text |Cite
|
Sign up to set email alerts
|

Circulating polyunsaturated fatty acids, pressure pain thresholds, and nociplastic pain conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 45 publications
0
9
0
Order By: Relevance
“…Specifically, DHA, one of the Omega-3 fatty acids, can reduce inflammation by inhibiting the synthesis of the inflammatory mediator prostaglandin E2 and combating oxidative stress ( 29 , 30 ). Additionally, studies have shown that higher ratios of Omega-6 to Omega-3 fatty acids are associated with an increased risk of cardiovascular disease, autoimmune diseases, and cancer ( 31 , 32 ). Therefore, maintaining a proper balance of omega-3 and Omega-6 fatty acid intake is crucial for maintaining good health.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, DHA, one of the Omega-3 fatty acids, can reduce inflammation by inhibiting the synthesis of the inflammatory mediator prostaglandin E2 and combating oxidative stress ( 29 , 30 ). Additionally, studies have shown that higher ratios of Omega-6 to Omega-3 fatty acids are associated with an increased risk of cardiovascular disease, autoimmune diseases, and cancer ( 31 , 32 ). Therefore, maintaining a proper balance of omega-3 and Omega-6 fatty acid intake is crucial for maintaining good health.…”
Section: Discussionmentioning
confidence: 99%
“…Analysis was conducted using a Waters Acquity Ultra-Performance Liquid Chromatography system tandem to a ThermoScientific TSQ Vantage as published [1] .…”
Section: Experimental Design Materials and Methodsmentioning
confidence: 99%
“…Table 1 shows detailed information about the LC-MS/MS methodology including retention time (min), precursor ion ( m/z ), product ion ( m/z ), and collision energy (V) for each compound. These parameters were used in the companion article to measure quantities of circulating PUFAs in human erythrocytes [1] . Though the companion article focused on EPA, ALA, DHA, ARA, and LA; the data for all 13 compounds are included in the data repository [2] .…”
Section: Data Descriptionmentioning
confidence: 99%
“…Utilizing the mechanism of nociplastic pain, a fibromyalgia-like mouse model was able to demonstrate that antagonization of the sigma-1 receptor resulted in alleviation long-term nociplastic pain, implicating its potential role in the mechanism [ 63 ]. In an analysis of 605 patients with or without chronic nociplastic pain conditions that commonly overlap (painful temporomandibular disorder, irritable bowel syndrome, fibromyalgia, low back pain, headache), a possible important difference was discovered in the polyunsaturated fatty acid (PUFA) levels [ 64 ]. It was found that a greater omega-6 (n-6) to omega-3 (n-6) PUFA ratio was associated with a greater number of comorbid conditions (i.e., suffered from multiple nociplastic pain conditions).…”
Section: Nociplastic Painmentioning
confidence: 99%
“…These possible biomarkers of nociplastic pain have been previously evidenced to metabolize in the body into pronociceptive oxylipins that increase the risk of hyperalgesia and allodynia [ 65 ]. This metabolism process likely involves lipoxygenase (LOX) or cytochrome P450 enzymes [ 64 ]. One study utilizing a mice model discovered that, unlike neuropathic pain, prostaglandins do not contribute significantly to nociplastic pain [ 66 ].…”
Section: Nociplastic Painmentioning
confidence: 99%